Radiotherapy News and Research

RSS

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

Launch of new cancer equipment

A new piece of equipment which has been installed at the University of Hertfordshire to train radiotherapy students to treat cancer patients will be launched at a Science and Engineering Week event on Tuesday (10th March).

5 Mar 2009

Stereotactic body radiotherapy doubles survival in lung cancer

Countless people have heard the phrase, "You have lung cancer," but only 50 can say they've completed a new treatment at Temple University that doubles their chances of surviving the deadly disease - and without the conventional radiation regimen or surgery.

4 Mar 2009

Radiation therapy equipment vendors to test system integration

The American Society for Radiation Oncology will host a connectathon at its headquarters in Fairfax, Va., this September as part of the Integrating the Healthcare Enterprise - Radiation Oncology (IHE-RO) initiative to promote seamless connectivity and integration of radiotherapy equipment and patient health information systems.

24 Feb 2009

Cancer Research UK launches first super cancer centre in Birmingham

Birmingham will become the first link in a unique chain of Cancer Research UK Centres to be launched round the country.

20 Feb 2009

Trial of Quadramet (153 Samarium-lexidronam) in combo with Velcade shows positive results

Quadramet (153 Samarium-lexidronam) is a radioactive medication that targets the bone, specifically bone cancer, and is used to treat pain caused by cancer that has metastasized or spread to the bone.

15 Feb 2009

Temozolomide sales reach $1 billion

Sales of Temozolomide, an anti-cancer drug developed by Cancer Research UK scientists, have reached $1 billion.

8 Feb 2009

Source of cancer stem cells' resistance to radiation discovered

Much to the dismay of patients and physicians, cancer stem cells - tiny powerhouses that generate and maintain tumor growth in many types of cancers - are relatively resistant to the ionizing radiation often used as therapy for these conditions.

5 Feb 2009

Scientists discover missing link in the way cells protect themselves against cancer

Cancer Research UK scientists have discovered a missing link in the way cells protect themselves against cancer, according to research published in Genes & Development.

5 Feb 2009

Revealed! - Missing link in how cells protect themselves from cancer

An international team of scientists have discovered a missing link in the method used by cells to protect themselves from cancer.

3 Feb 2009

Public information about breast screening in UK has serious shortcomings

The information about breast screening sent to women in the United Kingdom has serious shortcomings and should not be used as a basis for informed consent, warn researchers in a paper published on bmj.com today.

29 Jan 2009

Sequential and alternating chemotherapy and radiation equally effective in larynx cancer therapy

Larynx cancer patients treated with alternating cycles of chemotherapy and radiation have similar outcomes to patients treated with chemotherapy followed by radiation, according to data from a randomized controlled trial in the January 27 online issue of the Journal of the National Cancer Institute.

29 Jan 2009

Breakthrough in treatment of cancers and infectious diseases

Dr. André Veillette, a researcher at the Institut de recherches cliniques de Montréal (IRCM), and his team led by postdoctoral fellow Dr. Mario-Ernesto Cruz-Munoz, will publish in the upcoming issue of the prestigious journal Nature Immunology of Nature Publishing Group.

19 Jan 2009

UK survival for children's bone cancer lowest in Western Europe

Survival for childhood bone cancer is slightly lower in the UK than in any other Western European country, according to research published in the British Journal of Cancer today (Wednesday).

7 Jan 2009

Scientists find gene that is a powerful predictor of colon cancer metastasis

Cancer researchers have identified a gene which enables them to predict for the first time with high probability if colon cancer is going to metastasize.

22 Dec 2008

Merck KGaA acquires manufacturing rights for Stimuvax from Oncothyreon

Oncothyreon Inc. announced today that Merck KGaA of Darmstadt, Germany has licensed the right to manufacture Stimuvax and, through its affiliate EMD Serono Canada Inc., purchased current inventory and certain assets utilized for the manufacture of Stimuvax from Oncothyreon for consideration which includes net payments to Oncothyreon totaling approximately U.S. $13 million.

18 Dec 2008

New guidelines for malignant melanoma

The German Cancer Society has worked out new guidelines for the diagnosis and treatment of malignant melanoma - a disease with unfavorable prognosis.

18 Dec 2008

How cancer cells ensure their survival

A team of researchers headed by Professor Roland Stauber of Mainz University's ENT clinic has identified a molecular mechanism used by cancer cells to "defend" themselves against chemotherapeutics in an attempt to ensure their own survival.

17 Dec 2008

Research looks at link between normal and cancer stem cells

Scientists at St. Jude Children's Research Hospital have answered a central question in cancer biology: whether normal stem cells can give rise to tumors.

17 Dec 2008

$Lower-dose fractionated stereotactic radiotherapy results in better hearing preservation$

Lower-dose fractionated stereotactic radiotherapy results in better hearing preservation

Researchers at Thomas Jefferson University have found that a lower dose of fractionated stereotactic radiotherapy for acoustic neuromas results in better hearing preservation and has the same tumor local control rate as a higher dose of therapy.

17 Dec 2008

New anti-tumor gene called SARI

Researchers from Virginia Commonwealth University have identified a new anti-tumor gene called SARI that can interact with and suppress a key protein that is overexpressed in 90 percent of human cancers.

16 Dec 2008